|
1
|
Lee JA, Uhlik MT, Moxham CM, Tomandl D and
Sall DJ: Modern phenotypic drug discovery is a viable, neoclassic
pharma strategy. J Med Chem. 55:4527–4538. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Khazir J, Riley DL, Pilcher LA, De-Maayer
P and Mir BA: Anticancer agents from diverse natural sources. Nat
Prod Commun. 9:1655–1669. 2014.PubMed/NCBI
|
|
3
|
Cragg GM, Newman DJ and Yang SS: Natural
product extracts of plant and marine origin having antileukemia
potential. The NCI experience. J Nat Prod. 69:488–498. 2006.
View Article : Google Scholar
|
|
4
|
WHO Model List of Essential Medicines Home
Page. Aug 4–2016
|
|
5
|
Hopkins AL: Network pharmacology: The next
paradigm in drug discovery. Nat Chem Biol. 4:682–690. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Braz-Filho R: Contribuição da fitoquímica
para o desenvolvimento de um país emergente. Quim Nova. 33:229–239.
2010. View Article : Google Scholar
|
|
7
|
Dutra RC, Campos MM, Santos AR and Calixto
JB: Medicinal plants in Brazil: Pharmacological studies, drug
discovery, challenges and perspectives. Pharmacol Res. 112:4–29.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Franco-Salla GB, Prates J, Cardin LT, Dos
Santos AR, Silva WA Jr, da Cunha BR, Tajara EH, Oliani SM and
Rodrigues-Lisoni FC: Euphorbia tirucalli modulates gene expression
in larynx squamous cell carcinoma. BMC Complement Altern Med.
16:1362016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Prakash E and Gupta DK: Cytotoxic
activities of extracts of medicinal plants of euphorbiacae family
studied on seven human cancer cell lines. Univers J Plant Sci.
1:113–117. 2013.
|
|
10
|
Keating GM: Ingenol mebutate gel 0.015 and
0.05%: In actinic keratosis. Drugs. 72:2397–2405. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lebwohl M, Swanson N, Anderson LL,
Melgaard A, Xu Z and Berman B: Ingenol mebutate gel for actinic
keratosis. N Engl J Med. 366:1010–1019. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dutra RC, Bicca MA, Segat GC, Silva KA,
Motta EM, Pianowski LF, Costa R and Calixto JB: The antinociceptive
effects of the tetracyclic triterpene euphol in inflammatory and
neuropathic pain models: The potential role of PKCepsilon.
Neuroscience. 303:126–137. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Passos GF, Medeiros R, Marcon R,
Nascimento AF, Calixto JB and Pianowski LF: The role of PKC/ERK1/2
signaling in the anti-inflammatory effect of tetracyclic triterpene
euphol on TPA-induced skin inflammation in mice. Eur J Pharmacol.
698:413–420. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bani S, Kaul A, Khan B, Gupta VK, Satti
NK, Suri KA and Qazi GN: Anti-arthritic activity of a biopolymeric
fraction from Euphorbia tirucalli. J Ethnopharmacol. 110:92–98.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dutra RC, de Souza PR, Bento AF, Marcon R,
Bicca MA, Pianowski LF and Calixto JB: Euphol prevents experimental
autoimmune encephalomyelitis in mice: Evidence for the underlying
mechanisms. Biochem Pharmacol. 83:531–542. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang L, Wang G, Yang D, Guo X, Xu Y, Feng
B and Kang J: Euphol arrests breast cancer cells at the G1 phase
through the modulation of cyclin D1, p21 and p27 expression. Mol
Med Rep. 8:1279–1285. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin MW, Lin AS, Wu DC, Wang SS, Chang FR,
Wu YC and Huang YB: Euphol from Euphorbia tirucalli selectively
inhibits human gastric cancer cell growth through the induction of
ERK1/2-mediated apoptosis. Food Chem Toxicol. 50:4333–4339. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Santos OJ, Sauaia Filho EN, Nascimento FR,
Júnior FC, Fialho EM, Santos RH, Santos RA and Serra IC: Use of raw
Euphorbia tirucalli extract for inhibition of ascitic Ehrlich
tumor. Rev Col Bras Cir. 43:18–21. 2016.(In English, Portuguese).
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
MacNeil A, Sumba OP, Lutzke ML, Moormann A
and Rochford R: Activation of the Epstein-Barr virus lytic cycle by
the latex of the plant Euphorbia tirucalli. Br J Cancer.
88:1566–1569. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Silva-Oliveira RJ, Silva VA, Martinho O,
Cruvinel-Carloni A, Melendez ME, Rosa MN, de Paula FE, de Souza
Viana L, Carvalho AL and Reis RM: Cytotoxicity of allitinib, an
irreversible anti-EGFR agent, in a large panel of human
cancer-derived cell lines: KRAS mutation status as a predictive
biomarker. Cell Oncol(Dordr). 39:253–263. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dirks WG, Faehnrich S, Estella IA and
Drexler HG: Short tandem repeat DNA typing provides an
international reference standard for authentication of human cell
lines. Altex. 22:103–109. 2005.PubMed/NCBI
|
|
22
|
Yasukawa K, Akihisa T, Yoshida ZY and
Takido M: Inhibitory effect of euphol, a triterpene alcohol from
the roots of Euphorbia kansui, on tumour promotion by
12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in
mouse skin. J Pharm Pharmacol. 52:119–124. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dutra RC, Simao da Silva KA, Bento AF,
Marcon R, Paszcuk AF, Meotti FC, Pianowski LF and Calixto JB:
Euphol, a tetracyclic triterpene produces antinociceptive effects
in inflammatory and neuropathic pain: The involvement of
cannabinoid system. Neuropharmacology. 63:593–605. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Teixeira TL, Oliveira Silva VA, da Cunha
DB, Polettini FL, Thomaz CD, Pianca AA, Zambom FL, da Silva Leitão
Mazzi DP, Reis RM and Mazzi MV: Isolation, characterization and
screening of the in vitro cytotoxic activity of a novel L-amino
acid oxidase (LAAOcdt) from Crotalus durissus terrificus venom on
human cancer cell lines. Toxicon. 119:203–217. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Martinho O, Zucca LE and Reis RM: AXL as a
modulator of sunitinib response in glioblastoma cell lines. Exp
Cell Res. 332:1–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Martinho O, Silva-Oliveira R,
Miranda-Goncalves V, Clara C, Almeida JR, Carvalho AL, Barata JT
and Reis RM: In vitro and in vivo analysis of RTK inhibitor
efficacy and identification of its novel targets in glioblastomas.
Transl Oncol. 6:187–196. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chou TC and Talalay P: Quantitative
analysis of dose-effect relationships: The combined effects of
multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 22:27–55.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bruzzese F, Di Gennaro E, Avallone A, Pepe
S, Arra C, Caraglia M, Tagliaferri P and Budillon A: Synergistic
antitumor activity of epidermal growth factor receptor tyrosine
kinase inhibitor gefitinib and IFN-alpha in head and neck cancer
cells in vitro and in vivo. Clin Cancer Res. 12:617–625. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Konecny GE, Glas R, Dering J, Manivong K,
Qi J, Finn RS, Yang GR, Hong KL, Ginther C, Winterhoff B, et al:
Activity of the multikinase inhibitor dasatinib against ovarian
cancer cells. Br J Cancer. 101:1699–1708. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Moniz S, Martinho O, Pinto F, Sousa B,
Loureiro C, Oliveira MJ, Moita LF, Honavar M, Pinheiro C, Pires M,
et al: Loss of WNK2 expression by promoter gene methylation occurs
in adult gliomas and triggers Rac1-mediated tumour cell
invasiveness. Hum Mol Genet. 22:84–95. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Freedman VH and Shin SI: Cellular
tumorigenicity in nude mice: Correlation with cell growth in
semi-solid medium. Cell. 3:355–359. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Trendowski M: Recent advances in the
development of antineoplastic agents derived from natural products.
Drugs. 75:1993–2016. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Munro B, Vuong QV, Chalmers AC, Goldsmith
CD, Bowyer MC and Scarlett CJ: Phytochemical, antioxidant and
anti-cancer properties of Euphorbia tirucalli methanolic and
aqueous extracts. Antioxidants (Basel). 4:647–661. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Choene M and Motadi L: Validation of the
antiproliferative effects of Euphorbia tirucalli extracts in breast
cancer cell lines. Mol Biol (Mosk). 50:115–127. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Silva AC, de Faria DE, Borges NB, de Souza
IA, Peters VM and Guerra Mde O: Toxicological screening of
Euphorbia tirucalli L: Developmental toxicity studies in rats. J
Ethnopharmacol. 110:154–159. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Klemke RL, Cai S, Giannini AL, Gallagher
PJ, de Lanerolle P and Cheresh DA: Regulation of cell motility by
mitogen-activated protein kinase. J Cell Biol. 137:481–492. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Voutsadakis IA: Molecular predictors of
gemcitabine response in pancreatic cancer. World J Gastrointest
Oncol. 3:153–164. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wiedmann MW and Mossner J: New and
emerging combination therapies for esophageal cancer. Cancer Manag
Res. 5:133–146. 2013. View Article : Google Scholar : PubMed/NCBI
|
